Yan HB - Search Results

1

Risk Factors of Contrast-induced Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention.

Yuan Y, Qiu H, Hu XY, Luo T, Gao XJ, Zhao XY, Zhang J, Wu Y, Yan HB, Qiao SB, Yang YJ, Gao RL. Yuan Y, et al. Among authors: yan hb. Chin Med J (Engl). 2017 5th Jan 2017;130(1):45-50. doi: 10.4103/0366-6999.196578. Chin Med J (Engl). 2017. PMID: 28051022 Free PMC article.

2

Frequency of infarct-related artery with myocardial bridging in patients with ST-elevation myocardial infarction and its impact upon percutaneous coronary intervention.

Yan HB, Wang J, Zhu XL, Gao H, Li N, Ai H. Yan HB, et al. Chin Med J (Engl). 2006 Apr 5;119(7):539-43. Chin Med J (Engl). 2006. PMID: 16620693

3

Diver CE versus Guardwire Plus for thrombectomy in patients with inferior myocardial infarction: a trial of aspiration of thrombus during primary angioplasty for inferior myocardial infarction.

Yan HB, Wang J, Li N, Zhu XL, Gao H, Ai H, Li X, Ye M, Chi YP, Zhang H. Yan HB, et al. Chin Med J (Engl). 2007 Apr 5;120(7):557-61. Chin Med J (Engl). 2007. PMID: 17442202 Clinical Trial.

4

What is the optimal initiation timing of angiotensin converting enzyme inhibitor treatment for maximum benefits in acute myocardial infarction patients?

Yan HB, Wang SP. Yan HB, et al. Chin Med J (Engl). 2011 Feb;124(3):464-6. Chin Med J (Engl). 2011. PMID: 21362352

5

Comparison of safety and efficacy between fondaparinux and nadroparin in non-ST elevation acute coronary syndromes.

Yan HB, Song L, Liu R, Zhao HJ, Wang SP, Chi YP, Zheng B, Li WZ, Liu C, Zhou P. Yan HB, et al. Chin Med J (Engl). 2011 Mar;124(6):879-86. Chin Med J (Engl). 2011. PMID: 21518596 Clinical Trial.

6

Is it necessary to stent renal artery stenosis patients before cardiopulmonary bypass procedures?

Zheng B, Yan HB, Liu RF, Cheng SJ, Wang J, Zhao HJ, Song L. Zheng B, et al. Among authors: yan hb. Chin Med J (Engl). 2011 May;124(10):1453-7. Chin Med J (Engl). 2011. PMID: 21740797

7

Associated factors with repeat coronary angioplasty during the drug eluting stent era: a high volume center investigation.

Liu C, Yan HB, Zhao HJ, Song L, Zheng B, Chi YP, Wang SP, Wang J, Peng HY, Wu Z. Liu C, et al. Among authors: yan hb. Chin Med J (Engl). 2013 Feb;126(3):446-9. Chin Med J (Engl). 2013. PMID: 23422105

8

One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution.

Shen L, Hu S, Wang H, Xiong H, Zheng Z, Li L, Xu B, Yan H, Gao R. Shen L, et al. J Am Coll Cardiol. 2013 Jun 25;61(25):2525-33. doi: 10.1016/j.jacc.2013.04.007. Epub 2013 Apr 23. J Am Coll Cardiol. 2013. PMID: 23623906 Free article.

9

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial.

Gao RL, Xu B, Lansky AJ, Yang YJ, Ma CS, Han YL, Chen SL, Li H, Zhang RY, Fu GS, Yuan ZY, Jiang H, Huo Y, Li W, Zhang YJ, Leon MB; TARGET I Investigators. Gao RL, et al. EuroIntervention. 2013 May 20;9(1):75-83. doi: 10.4244/EIJV9I1A12. EuroIntervention. 2013. PMID: 23685298 Free article. Clinical Trial.

10

First report of a novel polymer-free dual-drug eluting stent in de novo coronary artery disease: results of the first in human BICARE trial.

Yu M, Xu B, Kandzari DE, Wu Y, Yan H, Chen J, Qian J, Qiao S, Yang Y, Gao RL. Yu M, et al. Catheter Cardiovasc Interv. 2014 Feb 15;83(3):405-11. doi: 10.1002/ccd.25129. Epub 2013 Aug 8. Catheter Cardiovasc Interv. 2014. PMID: 23857821 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters